Development and Validation of a Clostridium difficile Infection Risk Prediction Model Author ( s ) :

Objective. To develop and validate a risk prediction model that could identify patients at high risk for Clostridium difficile infection (CDI) before they develop disease. Design and Setting. Retrospective cohort study in a tertiary care medical center. Patients. Patients admitted to the hospital for at least 48 hours during the calendar year 2003. Methods. Data were collected electronically from the hospital's Medical Informatics database and analyzed with logistic regression to determine variables that best predicted patients' risk for development of CDI. Model discrimination and calibration were calculated. The model was bootstrapped 500 times to validate the predictive accuracy. A receiver operating characteristic curve was calculated to evaluate potential risk cutoffs. Results. A total of 35,350 admitted patients, including 329 with CDI, were studied. Variables in the risk prediction model were age, CDI pressure, times admitted to hospital in the previous 60 days, modified Acute Physiology Score, days of treatment with high-risk antibiotics, whether albumin level was low, admission to an intensive care unit, and receipt of laxatives, gastric acid suppressors, or antimotility drugs. The calibration and discrimination of the model were very good to excellent (C index, 0.88; Brier score, 0.009). Conclusions. The CDI risk prediction model performed well. Further study is needed to determine whether it could be used in a clinical setting to prevent CDI-associated outcomes and reduce costs.

[1]  K. Wilson,et al.  Acquisition of Clostridium difficile from the hospital environment. , 1988, American journal of epidemiology.

[2]  L. Peterson,et al.  Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. , 1990, The American journal of medicine.

[3]  R. D'Agostino,et al.  Development of health risk appraisal functions in the presence of multiple indicators: the Framingham Study nursing home institutionalization model. , 1995, Statistics in medicine.

[4]  K. Yuen,et al.  Clinical significance of alimentary tract microbes in bone marrow transplant recipients. , 1998, Diagnostic microbiology and infectious disease.

[5]  F. Harrell,et al.  Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study Group. , 1998, Statistics in medicine.

[6]  J. Clive,et al.  Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation , 1999, Bone Marrow Transplantation.

[7]  D. Milligan,et al.  Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.

[8]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[10]  C. Kelly,et al.  Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea , 2002, Infection Control & Hospital Epidemiology.

[11]  J. Winter,et al.  Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea , 2002, Bone Marrow Transplantation.

[12]  C. Kelly,et al.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Trends in enteric disease as a cause of death in the United States, 1989-1996. , 2003, American journal of epidemiology.

[14]  A. Huang,et al.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies , 2004, Canadian Medical Association Journal.

[15]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[16]  Mark A. Miller,et al.  Clostridium difficile: a formidable foe , 2004, Canadian Medical Association Journal.

[17]  Carlene A. Muto,et al.  A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use , 2005, Infection Control & Hospital Epidemiology.

[18]  L. Lanthier,et al.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Frank E. Harrell,et al.  Prognostic/Clinical Prediction Models: Development of a Clinical Prediction Model for an Ordinal Outcome: The World Health Organization Multicentre Study of Clinical Signs and Etiological Agents of Pneumonia, Sepsis and Meningitis in Young Infants , 2005 .

[20]  A. Barkun,et al.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[21]  J. Pépin,et al.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[23]  L. Valiquette,et al.  Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.

[24]  M. Owings,et al.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. , 2006, Emerging infectious diseases.

[25]  S. Suissa,et al.  Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy , 2006, Canadian Medical Association Journal.

[26]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[27]  Jane W. Marsh,et al.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Yan Yan,et al.  Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Jeanne E. Zack,et al.  Use of Hypochlorite Solution to Decrease Rates of Clostridium difficile-Associated Diarrhea , 2007, Infection Control & Hospital Epidemiology.

[30]  M. Olsen,et al.  Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. , 2007, Archives of internal medicine.

[31]  N. Cook.  Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. , 2008, Clinical chemistry.

[32]  G. D'Angelo,et al.  Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients , 2008, Emerging infectious diseases.

[33]  Helen Burstin,et al.  Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[34]  Jessina C. McGregor,et al.  Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points , 2008, Infection Control & Hospital Epidemiology.

[35]  L. Gentry,et al.  A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. , 2008, The Journal of hospital infection.

[36]  M. Olsen,et al.  Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  J. Tanner,et al.  Waterlow score to predict patients at risk of developing Clostridium difficile-associated disease. , 2009, The Journal of hospital infection.